Posted in | News | Light / Image Sensor

Validity Sensors Receives Strategic Investment from Intel Capital

Validity Sensors, Inc., the leader in Natural ID™ authentication, today announced that Intel Capital has completed a strategic investment as part of its Series E Financing.

Intel’s investment combined with additional strategic investments from World Fair and DDS brings the total Series E capital commitments to more than $22 million. This follows an initial closing on October 4, 2012, led by TeleSoft Partners that included full participation from Qualcomm Ventures, VentureTech Alliance (the venture capital arm of TSMC), Panorama Capital and Crosslink Capital.

“Validity’s technology addresses an important need to make computing devices and the transactions completed on them more secure while actually increasing ease of use for the end user,” said Dave Flanagan, Managing Director, Intel Capital. “This investment reflects our commitment to collaborate with the fingerprint sensor market leader to create differentiated products for mobile and computing platforms.”

“We are pleased with Intel Capital’s engagement and are excited about the opportunity to work with an industry leader who shares our vision for authentication,” said Rob Baxter, Chief Executive Officer, Validity. “This infusion of capital will enable us to extend our technology leadership and accelerate our products for mobile and tablet markets.”

Since launching its products in 2008, Validity has shipped more than 30 million sensors into consumer electronics products and is now focusing its resources on the multi-billion unit mobile phone and tablet markets that require convenient password authentication, improved mobile payment features and enhanced device navigation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.